Exhibit 10.2





 


EXECUTION VERSION





 





 


 BIOSCRIP, INC.


 


__________________________


 


WARRANT AGREEMENT


 


__________________________


 


Dated
As Of March 9, 2015


 


Warrants
to Purchase 3,600,000 shares of Common Stock


 


 


 




    	 



    	 



    




BIOSCRIP, INC.


 


Warrant Agreement





____________________________


 


Warrants For Common Stock


 


WARRANT AGREEMENT, dated as of March 9, 2015,
among BioScrip, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), Coliseum
Capital Partners, L.P., a Delaware limited partnership, Coliseum Capital Partners II, L.P., a Delaware limited partnership, and
Blackwell Partners, LLC, Series A, a Georgia limited liability company (collectively and together with each of their respective
successors and assigns, the “Purchasers”). Capitalized terms shall have the meaning specified in Section 5.1
hereof.


 


RECITALS


 


WHEREAS, the Purchasers have agreed to
acquire from the Company, and the Company has agreed to issue to the Purchasers, Warrants to purchase the number of shares of Common
Stock set forth opposite such Person’s name on Annex 1 attached hereto, which Warrants represent the right to
purchase, in the aggregate, 3,600,000 shares of Common Stock, subject to adjustment
as set forth herein;


 


WHEREAS, each Purchaser shall be issued two
separate Warrant Certificates, each representing one half of the total Warrants to be issued to that Purchaser, and each having
the same terms and conditions except for the Initial Exercise Price, with one Warrant Certificate being exercisable at $5.295
per share of Common Stock on the Issue Date (the “Warrant No. 1 Initial Exercise Price”) and the second
Warrant Certificate being exercisable at $6.595 per share of Common Stock on the Issue
Date (the “Warrant No. 2 Initial Exercise Price”); and


 


WHEREAS, the Company and the Purchasers
wish to enter into this Agreement to govern the terms of the Warrants.


 


AGREEMENT


 


NOW, THEREFORE, in consideration of the
premises and the mutual agreements set forth herein, the parties to this Agreement hereby agree as follows:


 


1.            FORM,
EXECUTION AND TRANSFER OF WARRANT CERTIFICATES.


 


1.1           Form
of Warrant Certificates.


 


The Warrant Certificates shall be in the form
set forth in Attachment A hereto. The Warrant Certificates may have such letters, numbers or other marks of identification
or designation as may be required to comply with any law or with any rule or regulation of any governmental authority, stock exchange
or self-regulatory organization made pursuant thereto (“Law”). Each Warrant Certificate shall be dated the date
of issuance thereof by the Company, either upon initial issuance or upon transfer or exchange. Each Warrant Certificate shall represent
the right to purchase the number of shares of Common Stock set forth in such Warrant Certificate at a price per share of Common
Stock equal to the Exercise Price applicable to that Warrant Certificate; provided, that the number of shares of Common
Stock issuable upon exercise of the Warrants and the Exercise Price thereof shall be subject to adjustment as provided herein.


 




    	-1-



    	 



    




1.2           Execution
of Warrant Certificates; Registration Books.


 


(a)          Execution
of Warrant Certificates. The Warrant Certificates shall be executed on behalf of the Company by an officer of the Company authorized
by the Board of Directors. In case the officer of the Company who shall have signed any Warrant Certificate shall cease to be such
an officer of the Company before issuance and delivery by the Company of such Warrant Certificate, such Warrant Certificate nevertheless
may be issued and delivered with the same force and effect as though the individual who signed such Warrant Certificate had not
ceased to be such an officer of the Company, and any Warrant Certificate may be signed on behalf of the Company by any individual
who, at the actual date of the execution of such Warrant Certificate, shall be a proper officer of the Company to sign such Warrant
Certificate, although at the date of the execution of this Agreement any such individual was not such an officer.


 


(b)          Registration
Books. The Company will keep or cause to be kept at its office, maintained at the address of the Company referenced in Section
6.5, at the Company’s transfer agent, or at such other office of the Company of which the Company shall have given notice
to each holder of Warrant Certificates, books for registration and transfer of the Warrant Certificates issued hereunder. Such
books shall show the names and addresses of the respective holders of the Warrant Certificates, the registration number and date
of each of the Warrant Certificates and the Denomination thereof.


 


1.3           Transfer,
Split Up, Combination and Exchange of Warrant Certificates; Lost or Stolen Warrant Certificates.


 


(a)             Transfer,
Split Up, etc.


 


(i)          Transfer.
Subject to compliance with the Securities Act and any applicable state securities laws, any Warrant Certificate (or portion thereof),
with or without other Warrant Certificates, may be transferred to any Person for a Warrant Certificate or Warrant Certificates
in an aggregate like Denomination as the Warrant Certificate or Warrant Certificates (or portions thereof) surrendered then entitled
such registered holder to purchase. Any registered holder desiring to transfer any Warrant Certificate shall make such request
in writing delivered to the Company, which request shall include the identity of the Transferee and the aggregate number of Warrants
to be transferred, and shall surrender the Warrant Certificate or Warrant Certificates (or portions thereof) to be transferred
at the office of the Company referenced in Section 6.5, whereupon the Company shall deliver promptly to such Transferee
a Warrant Certificate or Warrant Certificates, as the case may be, as so requested, which Warrant Certificate or Warrant Certificates
shall evidence, collectively, the same aggregate number of Warrants as the Warrant Certificate or Warrant Certificates (or portions
thereof) so surrendered for transfer and shall issue a new Warrant Certificate to the transferor representing the Warrants retained
by the Transferor if such transfer involved less than the entire number of Warrants held by such Transferor.


 




    	-2-



    	 



    




(ii)         Split
Up, Combination, Exchange, etc. Any Warrant Certificate, with or without other Warrant Certificates, may be split up, combined
or exchanged for another Warrant Certificate or Warrant Certificates, in an aggregate like Denomination as the Warrant Certificate
or Warrant Certificates surrendered then entitle such registered holder to purchase. Any registered holder desiring to split up,
combine or exchange any Warrant Certificate shall make such request in writing delivered to the Company, and shall surrender the
Warrant Certificate or Warrant Certificates to be split up, combined or exchanged at the office of the Company referenced in Section
6.5, whereupon the Company shall deliver promptly to such registered holder a Warrant Certificate or Warrant Certificates,
as the case may be, as so requested, which Warrant Certificate or Warrant Certificates shall evidence, collectively, the same aggregate
Denomination as the Warrant Certificate or Warrant Certificates so surrendered for split-up, combination or exchange.


 


(b)             Loss,
Theft, etc. Upon receipt by the Company of evidence reasonably satisfactory to it of the ownership of, and the loss, theft,
destruction or mutilation of, any Warrant Certificate, and:


 


(i)          in
the case of loss, theft or destruction, an affidavit of loss, together with a customary and reasonable indemnity; or


 


(ii)         in
the case of mutilation, upon surrender and cancellation thereof;


 


the Company at its own expense will execute
and deliver, in lieu thereof, a new Warrant Certificate, dated the date of such lost, stolen, destroyed or mutilated Warrant Certificate
and of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant Certificate and evidencing the same Denomination
as the Warrant Certificate so lost, stolen, destroyed or mutilated.


 


1.4           Subsequent
Issuance of Warrant Certificates.


 


Subsequent to the original issuance, no Warrant
Certificates shall be issued except:


 


(a)          Warrant
Certificates issued upon any transfer, combination, split up or exchange of Warrants pursuant to Section 1.3(a);


 


(b)          Warrant
Certificates issued in replacement of mutilated, destroyed, lost or stolen Warrant Certificates pursuant to Section 1.3(b);


 


(c)          Warrant
Certificates issued pursuant to Section 2.3 upon the partial exercise of any Warrant Certificate to evidence the unexercised
portion of such Warrant Certificate; and


 


(d)          Warrant
Certificates to reflect any adjustments pursuant to Section 4.


 




    	-3-



    	 



    




1.5           Effect
of Issuance in Registered Form.


 


Every holder of a Warrant Certificate by accepting
the same consents and agrees with the Company and with every other holder of a Warrant Certificate that:


 


(a)          the
Warrant Certificates, to the extent then currently transferable, are transferable only on the registry books of the Company if
and when surrendered at the office of the Company referenced in Section 6.5, duly endorsed or accompanied by an instrument
of transfer (in the form attached thereto) and payment of any applicable transfer, stamp or issue tax (a “Tax”);
and


 


(b)          the
Company may deem and treat the Person in whose name each Warrant Certificate is registered as the absolute owner thereof and of
the Warrants evidenced thereby (notwithstanding any notations of ownership or writing on the Warrant Certificates made by anyone
other than the Company) for all purposes whatsoever, and the Company shall not be affected by any notice to the contrary.


 


2.            EXERCISE
OF WARRANTS; PAYMENT OF EXERCISE PRICE.


 


2.1           Exercise
of Warrants.


 


(a)          Manner
of Exercise. At any time and from time to time prior to the Expiration Time, the holder of any Warrant Certificate may exercise
the Warrants evidenced thereby, in whole or in any part, by surrender to the Company, at its office referenced in Section 6.5,
of such Warrant Certificate, together with a duly executed election to purchase (a form of which is attached to each Warrant Certificate)
and payment of the applicable Exercise Price for each share of Common Stock with respect to which the Warrants are then being exercised
and an amount equal to any applicable Tax (if not payable by the Company as provided in Section 3.3). Such Exercise Price
shall be payable in cash pursuant to Section 2.1(b).


 


(b)          Payment
in Cash. Upon exercise of any Warrants, the holder of a Warrant Certificate may pay the Exercise Price by certified or official
bank check payable to the order of the Company or by wire transfer of immediately available funds to the account of the Company.


 


(c)          Fractional
shares of Common Stock. The Company may, in accordance with Section 2.6, pay the exercising holder cash in lieu of issuing
a fractional share in connection with an exercise of Warrants; provided that, if it does not issue a fractional share in such circumstances,
it will make such cash payment.


 


2.2           Issuance
of Common Stock.


 


Upon timely receipt of a Warrant Certificate,
accompanied by the form of election to purchase duly executed, and payment of the Exercise Price for each of the shares of the
Common Stock to be purchased and by an amount equal to any applicable Tax (if not payable by the Company as provided in Section
3.3), the Company shall thereupon promptly cause certificates representing the number of whole shares of Common Stock then
being purchased to be delivered to or upon the order of the registered holder of such Warrant Certificate, registered in such name
or names as may be designated by such holder, and, promptly after such receipt deliver the cash, if any, to be paid in lieu of
fractional shares pursuant to Section 2.6 to or upon the order of the registered holder of such Warrant Certificate.


 




    	-4-



    	 



    




2.3           Unexercised
Warrants.


 


In the event that the registered holder of any
Warrant Certificate shall exercise less than all the Warrants evidenced thereby, a new Warrant Certificate evidencing Warrants
equal in number to the number of Warrants remaining unexercised shall be issued by the Company to the registered holder of such
Warrant Certificate or to its duly authorized assigns.


 


2.4           Cancellation
and Destruction of Warrant Certificates.


 


All Warrant Certificates surrendered to the
Company for the purpose of exercise, exchange, substitution or transfer shall be cancelled by it, and no Warrant Certificates shall
be issued in lieu thereof except as expressly permitted by any of the provisions of this Agreement. The Company shall cancel and
retire any other Warrant Certificates purchased or acquired by the Company otherwise than upon the exercise thereof.


 


2.5           Expiration.


 


All Warrants that have not been exercised or
purchased in accordance with the provisions of this Agreement shall expire and all rights of holders of such Warrants shall terminate
and cease at the Expiration Time.


 


2.6           Fractional
shares of Common Stock.


 


The Company shall not be required to issue fractional
shares of Common Stock upon the exercise of any Warrant. If fractional shares are not issued upon the exercise of any Warrant,
there shall be paid to the holder thereof, in lieu of any fractional share of Common Stock resulting therefrom, an amount of cash
equal to the product of:


 


(a)          the
fractional amount of such share of Common Stock; and


 


(b)          the
Market Price, as determined on the trading day immediately prior to the date of exercise of such Warrant.


 


2.7           Limitation
on Conversion


 


Notwithstanding anything herein to the contrary,
prior to the receipt of the Stockholder Approval, the Warrants Beneficially Owned by any such holder of Warrants or its Affiliates
may not be converted pursuant to this Section 2 to the extent that after giving effect to such conversion, such holder and
its Affiliates would Beneficially Own, in the aggregate, in excess of 19.99% of the shares of Common Stock outstanding immediately
after giving effect to such conversion (the “Conversion Cap”); provided, further, that for purposes of
determining the Conversion Cap pursuant to any provision of this Agreement, the aggregate number of shares of Common Stock Beneficially
Owned by a holder of Warrants or any of its respective Affiliates shall include (i) the number of shares of Common Stock Beneficially
Owned by such holder or any of its respective Affiliates as a result of prior conversion of Convertible Preferred Stock or Warrants
(excluding shares of Common Stock that could be acquired upon conversion of the such Convertible Preferred Stock or Warrants) plus
(ii) the number of shares of Common Stock issuable upon the conversion of the Warrants with respect to which the determination
of the immediately preceding proviso is being made. Notwithstanding anything herein to the contrary, (x) if the first vote of the stockholders of the Company
with respect to the Stockholder Approval occurs within six months of the date hereof, then no Warrants may be converted into Common
Stock until the earlier of (1) the receipt of the Stockholder Approval and (2) the date that is six months after the date hereof
and (y) if the first vote of the stockholders of the Company with respect to the Stockholder Approval occurs after the date that
is six months after of the date hereof, then prior to the occurrence of the first vote of the stockholders of the Company with
respect to the Stockholder Approval, no Warrants may be converted into Common Stock.


 




    	-5-



    	 



    




3.          AGREEMENTS
OF THE COMPANY.


 


3.1           Reservation
of Common Stock.


 


The Company covenants and agrees that it will
at all times cause to be reserved and kept available out of its authorized and unissued shares of treasury shares of Common Stock
such number of shares of Common Stock as will be sufficient to permit the exercise in full of all Warrants issued hereunder into
Common Stock.


 


3.2           Common
Stock To Be Duly Authorized and Issued, Fully Paid and Nonassessable etc; Compliance with Law


 


The Company covenants and agrees that it will
take all such action as may be necessary to ensure that all shares of Common Stock delivered upon the exercise of any Warrant and
the payment of the Exercise Price pursuant to Section 2.1 (in each case, at the time of delivery of the certificates representing
such shares of Common Stock) shall (a) be duly and validly authorized and issued and fully paid and nonassessable, free of any
preemptive rights in favor of any Person in respect of such issuance and free of any security interest, pledge, mortgage, lien,
charge or other encumbrance created by, or arising out of actions of, the Company and (b) be issued without violation of any applicable
Law.


 


3.3           Taxes.


 


The Company covenants and agrees that it will
pay when due and payable any and all Taxes and charges that may be payable in respect of the initial issuance or delivery of:


 


(a)          each
Warrant Certificate;


 


(b)          each
Warrant Certificate issued in exchange for any other Warrant Certificate pursuant to Section 1.3, Section 2.3 or
Section 4; and


 


(c)          each
share of Common Stock issued upon the exercise of any Warrant.


 


The Company shall not, however, be required
to:


 


(i)          pay
any Tax that may be payable in respect of the transfer or delivery of Warrant Certificates in a name other than that of the registered
holder of the Warrant Certificate surrendered for exercise, conversion, transfer or exchange (any such Tax being payable by the
holder of such certificate at the time of surrender); or


 




    	-6-



    	 



    




(ii)         issue
or deliver any such certificates referred to in the foregoing clause (i) until any such Tax referred to in the foregoing clause
(i) shall have been paid.


 


3.4           Common
Stock Record Date.


 


Each Person in whose name any certificate for
shares of Common Stock is issued upon the exercise of Warrants shall for all purposes be deemed to have become the holder of record
of the Common Stock represented thereby on, and such certificates (if any) shall be dated, the date upon which the Warrant Certificate
evidencing such Warrants was duly surrendered with an election to purchase attached thereto duly executed and payment of the aggregate
Exercise Price (and any applicable Taxes, if payable by such Person) was made.


 


3.5           Rights
in Respect of Common Stock.


 


Prior to the exercise of the Warrants evidenced
thereby, the holder of a Warrant Certificate shall not be entitled to any rights of a stockholder of the Company with respect to
the Common Stock into which the Warrants shall be exercisable, including, without limitation, the right to vote in respect of any
matter upon which the holders of Common Stock may vote, the right to receive any distributions of cash or property and, except
as expressly set forth herein, the right to receive any notice of any proceedings of the Company. Prior to the exercise of the
Warrants evidenced thereby, the holders of the Warrant Certificates shall not have as such any obligation in respect of any assessment
or any other obligation or liability as a stockholder of the Company, whether such obligations or liabilities are asserted by the
Company or by creditors of the Company.


 


3.6           Noncircumvention.


 


The Company hereby covenants and agrees that
the Company will not, by amendment of its charter, bylaws or through any reorganization, transfer of assets, consolidation, merger,
scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms of this Warrant Agreement, and will at all times in good faith carry out all the provisions
of this Warrant Agreement.


 


4.          ANTI-DILUTION
ADJUSTMENTS.


 


4.1           Adjustments.


 


The number of shares of Common Stock purchasable
upon the exercise of each Warrant, and the Exercise Price, shall be subject to adjustment as set forth in this Section 4.


 




    	-7-



    	 



    




4.2           Stock
Splits, Subdivisions, Reclassifications or Combinations.


 


If the Company shall (i) declare and pay a dividend
or make a distribution on its Common Stock in shares of Common Stock, (ii) subdivide or reclassify the outstanding shares of Common
Stock into a greater number of shares, or (iii) combine or reclassify the outstanding shares of Common Stock into a smaller number
of shares, the number of shares of Common Stock issuable upon exercise of any Warrants at the time of the record date for such
dividend or effective date of such split, reverse split, subdivision, combination or reclassification shall be proportionately
adjusted so that the holder of such Warrants after such date shall be entitled to purchase the number of shares of Common Stock
which such holder would have owned or been entitled to receive in respect of the shares of Common Stock subject to such Warrants
after such date had such Warrants been exercised immediately prior to such date. In such event, the Exercise Price in effect at
the time of the effective date of such split, reverse split, subdivision, combination or reclassification shall be adjusted to
the number obtained by dividing (x) the product of (1) the number of shares of Common Stock issuable upon the exercise of such
Warrants before such adjustment and (2) the Exercise Price in effect immediately prior to the record or effective date, as the
case may be, for the dividend, distribution, split, reverse split, subdivision, combination or reclassification giving rise to
this adjustment by (y) the new number of shares of Common Stock issuable upon exercise of such Warrants determined pursuant to
the immediately preceding sentence; provided that the Exercise Price shall not be adjusted to be less than the par value of the
Common Stock.


 


4.3           Price
Based Anti-Dilution


 


(a)          Without
duplication of the adjustments set forth in Sections 4.2 or 4.4, if the Company shall issue or sell any shares of
Common Stock (as actually issued or, pursuant to Section 4.3(b), deemed to be issued) for a consideration per share less
than 85% of the Market Price per share immediately prior to such issuance or sale, or if earlier, upon the execution of the definitive
documentation with respect to such issuance or sale (the “Effective Time”), then immediately upon the Effective
Time the number of shares of Common Stock issuable upon exercise of any Warrants at the time of the effective date shall be increased
by multiplying such number of shares of Common Stock by a fraction, (i) the numerator of which shall be the Fully Diluted Number
of shares of Common Stock outstanding immediately prior to the Effective Time plus the number of shares of Common Stock so issued
or sold, and (ii) the denominator of which shall be the Fully Diluted Number of shares of Common Stock outstanding immediately
prior to the Effective Time plus the number of shares of Common Stock which the aggregate consideration received by the Company
for the total number of shares of Common Stock so issued or sold would purchase if such shares were sold at Market Price. For the
purposes of this Section 4.3(a), none of the following issuances shall be considered the issuance or sale of Common Stock:


 


(i)          the
issuance of the Convertible Preferred Stock;


 


(ii)         the
issuance of Common Stock upon the conversion of any then-outstanding Common Stock Equivalents (including the Convertible Preferred
Stock);


 


(iii)        the
issuance of any Common Stock or Common Stock Equivalents for which the adjustment provided in Section 4.2 applies; or


 


(iv)        the
issuance of shares of Common Stock or Common Stock Equivalents to Employees of the Company or any Company Subsidiary that is approved
by the Board of Directors.


 




    	-8-



    	 



    




(b)            For
the purposes of Section 4.3(a), the following subparagraphs (i) to (iii), inclusive, shall also be applicable:


 


(i)          If
the Company shall grant any rights to subscribe for, or any rights or options to purchase, Common Stock Equivalents, whether or
not such rights or options or the right to convert or exchange any such Common Stock Equivalents are immediately exercisable, and
the price per share for which Common Stock is issuable upon the exercise of such rights or options or upon conversion or exchange
of such Common Stock Equivalents (determined by dividing (A) the total amount, if any, received or receivable by the Company as
consideration for the granting of such rights or options, plus the minimum aggregate amount of additional consideration payable
to the Company upon the exercise of such rights or options, plus, in the case of any such rights or options which relate to such
Common Stock Equivalents, the minimum aggregate amount of additional consideration, if any, payable upon the issue or sale of such
Common Stock Equivalents and upon the conversion or exchange thereof, by (B) the total maximum number of shares of Common Stock
issuable upon the exercise of such rights or options or upon the conversion or exchange of all such Common Stock Equivalents issuable
upon the exercise of such rights or options) shall be less than the Market Price per share of Common Stock immediately prior to
the time of the granting of such rights or options, or, if earlier, the execution of definitive documentation with respect to such
grant, then the total maximum number of shares of Common Stock issuable upon the exercise of such rights or options or upon conversion
or exchange of the total maximum amount of such Common Stock Equivalents issuable upon the exercise of such rights or options shall
(as of the date of granting of such rights or options) be deemed to be outstanding and to have been issued for such price per share;
provided that no further adjustment of the conversion price pursuant to this Section 4.3(b)(i) shall be made (i) upon
the actual issuance or sale of such Common Stock Equivalents upon the exercise of any rights to subscribe for, or any rights or
options to purchase, such Common Stock Equivalents or (ii) upon the actual issuance or sale of such Common Stock upon the exercise
of any such Common Stock Equivalents, including without limitation, in each case of clauses (i) and (ii) with respect to shares
of Common Stock Equivalents or Common Stock issued or issuable as a result of the effect of antidilution adjustments under any
such security.


 


(ii)         If
the Company shall issue or sell any Common Stock Equivalents, whether or not the rights to exchange or convert thereunder are immediately
exercisable, and the price per share for which Common Stock is issuable upon such conversion or exchange (determined by dividing
(A) the total amount received or receivable by the Company as consideration for the issue or sale of such Common Stock Equivalents,
plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the conversion or exchange thereof,
by (B) the total maximum number of shares of Common Stock issuable upon the conversion or exchange of all such Common Stock Equivalents)
shall be less than the Market Price per share of Common Stock immediately prior to the Effective Time, then the total maximum number
of shares of Common Stock issuable upon conversion or exchange of such Common Stock Equivalents shall (as of the date of the issue
or sale of such Common Stock Equivalents) be deemed to be outstanding and to have been issued for such price per share, provided
that no further adjustment of the conversion price pursuant to this Section 4.3(b)(ii) shall be made upon the actual issuance
or sale of such Common Stock upon the exercise of any such Common Stock Equivalents, including without limitation, in each case
with respect to shares of Common Stock issued or issuable as a result of the effect of antidilution adjustments under any such
security.


 




    	-9-



    	 



    




(iii)        In
case at any time any shares of Common Stock or Common Stock Equivalents or any rights or options to purchase any such Common Stock,
or Common Stock Equivalents shall be issued or sold for cash, the consideration received therefor shall be deemed to be the amount
received by the Company therefor. In case any shares of Common Stock or Common Stock Equivalents or any rights or options to purchase
any such Common Stock or Common Stock Equivalents shall be issued or sold for a consideration other than cash, the amount of the
consideration other than cash received by the Company shall be deemed to be the Fair Market Value of such consideration.


 


4.4           Other
Distributions.


 


In case the Company shall fix a record date
for the making of a dividend or distribution to all holders of shares of its Common Stock of securities, evidences of indebtedness,
assets, cash, rights or warrants (excluding dividends of its Common Stock and other dividends or distributions referred to in Section
4.2), in each such case, the Exercise Price in effect prior to such record date shall be reduced immediately thereafter to
the price determined by multiplying the Exercise Price in effect immediately prior to the reduction by the quotient of (x) the
Market Price of the Common Stock on the last trading day preceding the first date on which the Common Stock trades on the Exchange
on which the Common Stock is listed or admitted to trading without the right to receive such distribution, minus the amount of
cash and/or the Fair Market Value of the securities, evidences of indebtedness, assets, rights or warrants to be so distributed
in respect of one share of Common Stock (such amount and/or Fair Market Value, the “Per Share Fair Market Value”)
divided by (y) such Market Price on such date specified in clause (x); such adjustment shall be made successively whenever such
a record date is fixed. In such event, the number of shares of Common Stock issuable upon the exercise of any Warrants shall be
increased to the number obtained by dividing (x) the product of (1) the number of shares of Common Stock issuable upon the exercise
of such Warrants before such adjustment, and (2) the Exercise Price in effect immediately prior to the distribution giving rise
to this adjustment by (y) the new Exercise Price determined in accordance with the immediately preceding sentence. In the event
that such distribution is not so made, the Exercise Price and the number of shares of Common Stock issuable upon exercise of such
Warrants then in effect shall be readjusted, effective as of the date when the Board of Directors determines not to distribute
such shares, evidences of indebtedness, assets, rights, cash or warrants, as the case may be, to the Exercise Price that would
then be in effect and the number of shares of Common Stock that would then be issuable upon exercise of such Warrants if such record
date had not been fixed.


 




    	-10-



    	 



    




4.5           Business
Combinations.


 


In case of any Business Combination or reclassification
of Common Stock (other than a reclassification of Common Stock referred to in Section 4.2), a holder’s right to receive
shares of Common Stock upon exercise of any Warrants shall be converted into the right to exercise such Warrant to acquire the
number of shares of stock or other securities or property (including cash) which the Common Stock issuable (at the time of such
Business Combination or reclassification) upon exercise of such Warrants immediately prior to such Business Combination or reclassification
would have been entitled to receive upon consummation of such Business Combination or reclassification; and in any such case, if
necessary, the provisions set forth herein with respect to the rights and interests thereafter of such holder shall be appropriately
adjusted so as to be applicable, as nearly as may reasonably be, to such holder’s right to exercise such Warrants in exchange
for any shares of stock or other securities or property pursuant to this Section 4.5; provided that a holder’s right
to receive cash consideration under this Section 4.5 shall be subject to the prior indefeasible payment in full in cash
of all outstanding Indebtedness and other obligations under the Credit Facility (and the termination of all commitments thereunder)
and the Indenture (after the termination of all commitments thereunder), each as defined in the Certificate of Designations, to
the extent the outstanding Common Stock’s right to receive cash in such transaction is subject to such payment. In determining
the kind and amount of stock, securities or the property receivable upon exercise of any Warrants following the consummation of
such Business Combination, if the holders of Common Stock have the right to elect the kind or amount of consideration receivable
upon consummation of such Business Combination, then the holder of such Warrants shall be entitled to elect the kind or amount
of consideration receivable upon consummation of such Business Combination. The Company shall not enter into or be party to any
Business Combination unless the successor of the Company (if any), assumes in writing all of the obligations of the Company under
this Warrant Agreement pursuant to written agreements, including agreements to deliver to each holder of Warrants hereunder in
exchange for such Warrants a security of such successor evidenced by a written instrument substantially similar in form and substance
to this Warrant Agreement.


 


4.6           Expiration
of Rights or Options.


 


Upon the expiration of any rights or options
to subscribe for, purchase or convert or exchange Common Stock or Common Stock Equivalents in respect of the issuance, sale or
grant of which adjustment was made pursuant to Section 4.3, without the exercise thereof, the Exercise Price and the number
of shares of Common Stock purchasable upon the exercise of each Warrant shall, upon such expiration, be readjusted and shall thereafter
be such Exercise Price and such number of shares of Common Stock as would have been had such Exercise Price and such number of
shares of Common Stock not been originally adjusted (or had the original adjustment not been required, as the case may be), as
if:


 


(a)          the
only shares of Common Stock so issued were the shares of Common Stock, if any, actually issued or sold upon the exercise of such
rights or options; and


 


(b)          such
shares of Common Stock, if any, were issued or sold for the consideration actually received by the Company upon such exercise plus
the aggregate consideration, if any, actually received by the Company for the issuance, sale or grant of all of such rights or
options, whether or not exercised; provided that no such readjustment shall have the effect of increasing the Exercise Price by
an amount in excess of the amount of the reduction initially made in respect of the issuance, sale, or grant of such rights or
options.


 




    	-11-



    	 



    

 


4.7           Rounding
of Calculations; Minimum Adjustments.


 


All calculations under this Section 4
shall be made to the nearest one-tenth (1/10th) of a cent or to the nearest one-hundredth (1/100th) of a share, as the case may
be. Any provision of this Section 4 to the contrary notwithstanding, no adjustment in the Exercise Price or the number of
shares of Common Stock into which any Warrants are exercisable shall be made if the amount of such adjustment would be less than
$0.01 or one-tenth (1/10th) of a share of Common Stock, but any such amount shall be carried forward and an adjustment with respect
thereto shall be made at the time of and together with any subsequent adjustment which, together with such amount and any other
amount or amounts so carried forward, shall aggregate $0.01 or 1/10th of a share of Common Stock, or more.


 


4.8           Timing
of Issuance of Additional Common Stock Upon Certain Adjustments.


 


In any case in which the provisions of this
Section 4 shall require that an adjustment shall become effective immediately after a record date for an event, the Company
may defer until the occurrence of such event (i) issuing to the holder of any Warrants exercised after such record date and before
the occurrence of such event the additional shares of Common Stock issuable upon such exercise by reason of the adjustment required
by such event over and above the shares of Common Stock issuable upon such exercise before giving effect to such adjustment and
(ii) paying to such holder any amount of cash in lieu of a fractional share of Common Stock; provided, however, that the
Company upon request shall deliver to such holder a due bill or other appropriate instrument evidencing such holder’s right
to receive such additional shares, and such cash, upon the occurrence of the event requiring such adjustment.


 


4.9           Miscellaneous.


 


(a)          Statement
Regarding Adjustments. Whenever the Exercise Price or the number of shares of Common Stock into which any Warrants are exercisable
shall be adjusted as provided in Section 4, the Company shall forthwith file at the principal office of the Company referenced
in Section 6.5 a statement showing in reasonable detail the facts requiring such adjustment and the Exercise Price that
shall be in effect and the number of shares of Common Stock into which such Warrants shall be exercisable after such adjustment,
and the Company shall also cause a copy of such statement to be sent by mail, first class postage prepaid, to each holder of Warrants
at the address appearing in the Company’s records.


 


(b)          Notice
of Adjustment Event. In the event that the Company shall propose to take any action of the type described in this Section
4 (but only if the action of the type described in this Section 4 would result in an adjustment in the Exercise Price
or the number of shares of Common Stock into which Warrants are exercisable or a change in the type of securities or property to
be delivered upon exercise of Warrants), the Company shall give notice to the holders of Warrants, in the manner set forth in Section
4.8(a), which notice shall specify the record date, if any, with respect to any such action and the approximate date on which
such action is to take place. Such notice shall also set forth the facts with respect thereto as shall be reasonably necessary
to indicate the effect on the Exercise Price and the number, kind or class of shares or other securities or property which shall
be deliverable upon exercise of any Warrants. In the case of any action which would require the fixing of a record date, such notice
shall be given at least 10 days prior to the date so fixed, and in case of all other action, such notice shall be given at least
15 days prior to the taking of such proposed action. Without limiting the foregoing, to the extent notice of any of the foregoing
actions or events is given to the holders of the Common Stock, such notice shall be provided to the holders of the Warrants on
or before such notice to the holders of Common Stock.


 




    	-12-



    	 



    

 


(c)          Proceedings
Prior to Any Action Requiring Adjustment. As a condition precedent to the taking of any action which would require an adjustment
pursuant to this Section 4, the Company shall take any action which may be necessary, including obtaining regulatory, New
York Stock Exchange, NASDAQ Stock Market or other applicable national securities exchange (an “Exchange”) or
stockholder approvals or exemptions, in order that the Company may thereafter validly and legally issue as fully paid and nonassessable
all shares of Common Stock that the holders are entitled to receive upon exercise of this any Warrants pursuant to this Section
4.


 


(d)          Adjustment
Rules. Any adjustments pursuant to this Section 4 shall be made successively whenever an event referred to herein shall
occur. If more than one subsection of this Section 4 is applicable to a single event, the subsection shall be applied that
produces the largest adjustment and no single event shall cause an adjustment under more than one subsection of this Section
4 so as to result in duplication. If an adjustment in Exercise Price made hereunder would reduce the Exercise Price to an amount
below par value of the Common Stock, then such adjustment in Exercise Price made hereunder shall reduce the Exercise Price to the
par value of the Common Stock.


 


5.            INTERPRETATION
OF THIS AGREEMENT.


 


5.1           Certain
Defined Terms.


 


For the purpose of this Agreement, the following
terms shall have the meanings set forth below or set forth in the Section hereof following such term:


 


“Affiliate” means, with respect
to any Person, (a) a director, officer or shareholder of such Person, (b) a spouse, parent, sibling or descendant of such Person
(or spouse, parent, sibling or descendant of any director or executive officer of such Person) and (c) any other Person that, directly
or indirectly through one or more intermediaries, Controls, or is Controlled by, or is under common Control with, such Person,
at such time; provided, however, that none of the Purchasers shall be deemed to be an “Affiliate” of the Company and
no Person holding any one or more of the Warrants shall be deemed to be an “Affiliate” of the Company solely by virtue
of the ownership thereof.


 


“Agreement” means this Warrant
Agreement as it may from time to time be amended, restated, modified or supplemented.


 


“Board of Directors” means
the board of directors of the Company, including any duly authorized committee thereof.


 


“Beneficially Own” has the
meaning set forth in the Certificate of Designations.


 


“Business Combination” means
any consolidation of the Company with, or merger of the Company with or into, another Person (other than a merger in which (a)
the Company is the surviving corporation, (b) that does not result in any reclassification or change of shares of Common Stock
outstanding immediately prior to such merger and (c) the holders of Common Stock are not entitled to receive any consideration
therefrom), or any sale or conveyance to another Person of the assets of the Company substantially as an entirety.


 




    	-13-



    	 



    

 


“business day” means any
day that is not a Saturday, Sunday or other day on which banking institutions in New York, New York are authorized or required
by Law or executive order to close.


 


“Capital Stock” means (A)
with respect to any Person that is a corporation or company, any and all shares, interests, participations or other equivalents
(however designated) of capital or capital stock of such Person and (B) with respect to any Person that is not a corporation or
company, any and all partnership or other equity interests of such Person.


 


“Certificate of Designations”
shall mean this Certificate of Designations relating to the Convertible Preferred Stock, as it may be amended from time to time.


 


“Charter” means, with respect
to any Person, its certificate or articles of incorporation, articles of association, or similar organizational document.


 


“Common Stock” means the
Company’s common stock, par value $.0001 per share.


 


“Common Stock Equivalents”
means outstanding Warrants or other securities convertible or exchangeable into Common Stock, including the Preferred Convertible
Stock.


 


“Company” has the meaning
set forth in the introductory paragraph hereof.


 


“Convertible Preferred Stock”
means the Series A convertible preferred stock issued to the Purchasers pursuant to that certain securities purchase agreement,
entered into on the date hereof, by and between the Company and the Purchasers.


 


“Control” means, with respect
to any Person, the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
of such Person, whether through the ownership of voting Securities, by contract or otherwise.


 


“Denomination” means, in
the case of any Warrant Certificate, the number of shares of Common Stock issuable upon exercise of such Warrant Certificate represented
thereby.


 


“Effective Time” has the
meaning set forth in Section 4.3(a).


 


“Exchange” has the set forth
in Section 4.9(c).


 


“Exchange Act” means the
Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated thereunder.


 


“Exercise Price” means, prior
to any adjustment pursuant to Section 4 of this Agreement, the Initial Exercise Price; and thereafter, the Initial Exercise
Price as successively adjusted and readjusted from time to time in accordance with the provisions of Section 4.


 




    	-14-



    	 



    

 


“Expiration Time” means 5:00
p.m., Eastern time, on the tenth (10th) year anniversary of the date hereof.


 


“Fair Market Value” means,
with respect to any security or other property, the fair market value of such security or other property as determined by the Board
of Directors, acting in good faith. The Required Warrantholders may object in writing to the Board of Director’s calculation
of Fair Market Value within 10 days of receipt of written notice thereof. If the Required Warrantholders and the Board of Directors
are unable to agree on Fair Market Value during the 10-day period following the delivery of the Required Warrantholders’
objection, then the Board of Directors shall select and approve an appraiser experienced in the business of evaluating or appraising
the market value of securities (which appraiser shall be subject to approval by the Required Warrantholders, which approval shall
not be unreasonably withheld). The Fair Market Value established by such appraiser shall be conclusive and binding on the parties.
In the event the Fair Market Value established by such appraiser is greater than the Fair Market Value previously determined by
the Board of Directors, the fees and expenses for such appraiser shall be borne by the Company. In the event the Fair Market Value
established by such appraiser is less than or equal to the Fair Market Value previously determined by the Board of Directors, the
fees and expenses for such appraiser shall be borne by the holders of Warrants.


 


“Fully Diluted Number of Common Shares”
means the sum of (i) all shares of Common Stock actually outstanding (which shall in no event include the Common Stock to be so
issued and sold and for which Section 4.3 is being applied) and (ii) all shares of Common Stock issuable upon conversion
or exchange of the Common Stock Equivalents.


 


“Initial Exercise Price”
means, with respect to each Warrant Certificate issued to a Purchaser, the Warrant No. 1 Initial Exercise Price or the Warrant
No. 2 Initial Exercise Price, as assigned to that Warrant Certificate.


 


“Issue Date” means March
9, 2015.


 


“Law” has the set forth in
Section 1.1.


 


“Market Price” means, with
respect to a particular security, on any given day, the last reported sale price or, in case no such reported sale takes place
on such day, the average of the last closing bid and ask prices, in either case on the Exchange on which the applicable securities
are listed or admitted to trading. “Market Price” shall be determined without reference to after hours or extended
hours trading. If such security is not listed and traded in a manner that the quotations referred to above are available for the
period required hereunder, the Market Price per share of Common Stock shall be deemed to be the fair market value per share of
such security as determined in good faith by the Board of Directors in reliance on an opinion of a nationally recognized independent
investment banking corporation retained by the Company for this purpose (which opinion shall be made available to the holders of
Warrants); provided that the Required Warrantholders may object in writing to the Board of Director’s calculation of fair
market value within 10 days of receipt of written notice thereof. If the Required Warrantholders and the Board of Directors are
unable to agree on fair market value during the 10-day period following the delivery of the Required Warrantholders’ objection,
then the Board of Directors shall select and approve an appraiser experienced in the business of evaluating or appraising the market
value of securities (which appraiser shall be subject to approval by the Required Warrantholders, which approval shall not be unreasonably
withheld). The Market Price established by such appraiser shall be conclusive and binding on the parties. In the event the Market
Price established by such appraiser is greater than the Market Price previously determined by the Board of Directors, the fees
and expenses for such appraiser shall be borne by the Company. In the event the Market Price established by such appraiser is less
than or equal to the Market Price previously determined by the Board of Directors, the fees and expenses for such appraiser shall
be borne by the holders of Warrants. For the purposes of determining the Market Price of the Common Stock on the “trading
day” preceding, on or following the occurrence of an event, (i) that trading day shall be deemed to commence immediately
after the regular scheduled closing time of trading on the Nasdaq Stock Market or, if trading is closed at an earlier time, such
earlier time and (ii) that trading day shall end at the next regular scheduled closing time, or if trading is closed at an earlier
time, such earlier time (for the avoidance of doubt, and as an example, if the Market Price is to be determined as of the last
trading day preceding a specified event and the closing time of trading on a particular day is 4:00 p.m. and the specified event
occurs at 5:00 p.m. on that day, the Market Price would be determined by reference to such 4:00 p.m. closing price).


 




    	-15-



    	 



    

 


 


“Per Share Fair Market Value”
has the meaning set forth in Section 4.4.


 


“Person” has the meaning
given to it in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act.


 


“Purchasers” has the meaning
set forth in the introductory paragraph hereof.


 


“Required Warrantholders”
means, at any time, the holders of Warrants representing at least a majority of the Common Stock issuable upon exercise of the
Warrants issued hereunder and outstanding (exclusive of any Warrants directly or indirectly held by the Company or any Affiliate
of the Company).


 


“Securities Act” means the
Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated thereunder.


 


“Stockholder Approval” has
the meaning set forth in the Certificate of Designations.


 


“Tax” or “Taxes”
has the meaning set forth in Section 1.5(a).


 


“trading day” means (A) if
the shares of Common Stock are not traded on any national or regional securities exchange or association or over-the-counter market,
a business day or (B) if the shares of Common Stock are traded on any national or regional securities exchange or association or
over-the-counter market, a business day on which such relevant exchange or quotation system is scheduled to be open for business
and on which the shares of Common Stock (i) are not suspended from trading on any national or regional securities exchange or association
or over-the-counter market for any period or periods aggregating one half hour or longer; and (ii) have traded at least once on
the national or regional securities exchange or association or over-the-counter market that is the primary market for the trading
of the shares of Common Stock.


 




    	-16-



    	 



    

 


“Transferee” means any registered
transferee of all or any part of any one or more Warrant Certificates initially acquired by the Purchasers under this Agreement.


 


“U.S. GAAP” means United
States generally accepted accounting principles.


 


“Warrant” means a warrant
to initially purchase one share of Common Stock issued pursuant to this Agreement.


 


“Warrant Certificate” means
a certificate evidencing the Warrants in the form of Attachment A.


 


“Warrant No. 1 Initial Exercise Price”
has the meaning set forth in the recitals.


 


“Warrant No. 2 Initial Exercise Price”
has the meaning set forth in the recitals.


 


5.2           Section
Heading and Table of Contents and Construction.


 


(a)          Section
Headings and Table of Contents, etc. The titles of the Sections of this Agreement and the Table of Contents of this Agreement
appear as a matter of convenience only, do not constitute a part hereof and shall not affect the construction hereof. The words
“herein,” “hereof,” “hereunder” and “hereto” refer to this Agreement as a whole
and not to any particular Section or other subdivision. References to Sections are, unless otherwise specified, references to Sections
of this Agreement. References to Annexes and Attachments are, unless otherwise specified, references to Annexes and Attachments
attached to this Agreement.


 


(b)          Independent
Construction. Each covenant contained herein shall be construed (absent an express contrary provision herein) as being independent
of each other covenant contained herein, and compliance with any one covenant shall not (absent such an express contrary provision)
be deemed to excuse compliance with one or more other covenants.


 


5.3           Directly
or Indirectly.


 


Where any provision herein refers to action
to be taken by any Person, or which such Person is prohibited from taking, such provision shall be applicable whether such action
is taken directly or indirectly by such Person, including actions taken by or on behalf of any partnership in which such Person
is a general partner.


 


5.4           Governing
Law.


 


THIS AGREEMENT AND THE WARRANT CERTIFICATES
SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE INTERNAL LAWS OF THE
STATE OF NEW YORK, WITHOUT GIVING EFFECT TO THE CONFLICT OF LAWS RULES THEREOF TO THE EXTENT THAT ANY SUCH RULES WOULD REQUIRE
OR PERMIT THE APPLICATION OF THE LAWS OF ANY OTHER JURISDICTION, EXCEPT TO THE EXTENT THAT THE DELAWARE GENERAL CORPORATION LAW
SPECIFICALLY AND MANDATORILY APPLIES.


 




    	-17-



    	 



    

 


6.            MISCELLANEOUS.


 


6.1           Expenses.


 


Issuance of certificates for shares of Common
Stock to a holder upon the exercise of any Warrants shall be made without charge to such holder for any Tax or other incidental
expense in respect of the issuance of such certificates, all of which Taxes and expenses shall be paid by the Company (other than
the Taxes not payable by the Company pursuant to Section 3.3).


 


6.2           Amendment
and Waiver.


 


This Agreement may be amended, and the observance
of any term of this Agreement may be waived, with and only with the written consent of the Company and the Required Warrantholders;
provided, however, that no amendment or waiver of the provisions of this Section 2.1, Section 6.2, Section 4
or of any term defined in Section 5.1 to the extent used herein or therein, may be made without the prior written consent
of all holders of Warrants then outstanding (excluding any Warrants directly or indirectly held by the Company or any Affiliate
of the Company); and, provided, further, that


 


(a)          no
such amendment or waiver of any of the provisions of this Agreement pertaining to the Exercise Price or the number of shares or
kind of Common Stock that may be purchased upon exercise of each Warrant; and


 


(b)          no
change accelerating the occurrence of the Expiration Time; shall be effective as to a holder of Warrants unless consented to in
writing by such holder.


 


6.3           Entire
Agreement.


 


This Agreement and the Warrant Certificates
embody the entire agreement and understanding among the Company and the Purchasers, and supersede all prior agreements and understandings,
relating to the subject matter hereof.


 


6.4           Successors
and Assigns.


 


All covenants and other agreements in this Agreement
made by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors and assigns
of the parties hereto to the extent they become holders of Warrants (including, without limitation, any Transferee) whether so
expressed or not. Notwithstanding the foregoing sentence, the Company may not assign any of its rights, duties or obligations hereunder
or under the Warrant Certificates without the prior written consent of the Required Warrantholders.


 


6.5           Notices.


 


All communications hereunder or under the Warrants
shall be in writing and shall be delivered either by certified or registered mail, postage pre-paid, return receipt requested,
or nationally recognized overnight courier, and shall be addressed to the following addresses:


 




    	-18-



    	 



    

 





(a)          if
to a Purchaser, at its address set forth on Annex 2 to this Agreement, or at such other address as such Purchaser shall have specified
to the Company in writing;


 


(b)          if
to any other holder of any Warrant Certificate, addressed to such other holder at such address as such other holder shall have
specified to the Company in writing or, if any such other holder shall not have so specified an address to the Company, then addressed
to such other holder in care of the last holder of such Warrant Certificate that shall have so specified an address to the Company;
and


 


(c)          if
to the Company, at the address set forth on Annex 3 to this Agreement, or at such other address as the Company shall have specified
to each holder of Warrants in writing.


 


Any communication addressed and delivered as
herein provided shall be deemed to be received when actually delivered to the address of the addressee (whether or not delivery
is accepted) by a nationally recognized overnight delivery service which provides proof of delivery or on the date postmarked if
sent by registered or certified mail, as the case may be. Any communication not so addressed and delivered shall be ineffective
unless actually received by the intended addressee. Notwithstanding the foregoing provisions of this Section 6.5, service
of process in any suit, action or proceeding arising out of or relating to this Agreement or any document, agreement or transaction
contemplated hereby shall be delivered in the manner provided in Section 6.8(c).


 


6.6           Severability.


 


Any provision of this Agreement that is prohibited
or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability
without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not
invalidate or render unenforceable such provision in any other jurisdiction.


 


6.7           Execution
in Counterpart.


 


This Agreement may be executed in one or more
counterparts and shall be effective when at least one counterpart shall have been executed by each party hereto, and each set of
counterparts that, collectively, show execution by each party hereto shall constitute one duplicate original.


 


6.8           Waiver
of Jury Trial; Consent to Jurisdiction, Etc.


 


(a)          Waiver
of Jury Trial. THE PARTIES HERETO VOLUNTARILY AND INTENTIONALLY WAIVE ANY RIGHT ANY OF THEM MAY HAVE TO A TRIAL BY JURY IN
RESPECT OF ANY LITIGATION ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE WARRANTS OR ANY OF THE DOCUMENTS, AGREEMENTS
OR TRANSACTIONS CONTEMPLATED HEREBY.


 




    	-19-



    	 



    

 


(b)          Consent
to Jurisdiction. ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE WARRANTS, OR ANY OF THE
DOCUMENTS, AGREEMENTS OR TRANSACTIONS CONTEMPLATED HEREBY (WHETHER IN TORT, CONTRACT OR OTHERWISE) OR ANY ACTION OR PROCEEDING
TO EXECUTE OR OTHERWISE ENFORCE ANY JUDGMENT IN RESPECT OF ANY BREACH UNDER THIS AGREEMENT, THE WARRANTS OR ANY DOCUMENT OR AGREEMENT
CONTEMPLATED HEREBY SHALL BE BROUGHT BY SUCH PARTY IN ANY NEW YORK STATE COURT OR FEDERAL DISTRICT COURT LOCATED IN THE SOUTHERN
DISTRICT OF NEW YORK AS SUCH PARTY MAY IN ITS SOLE DISCRETION ELECT, AND BY THE EXECUTION AND DELIVERY OF THIS AGREEMENT, THE PARTIES
HERETO IRREVOCABLY AND UNCONDITIONALLY SUBMIT TO THE IN PERSONAM JURISDICTION OF EACH SUCH COURT, AND EACH OF THE PARTIES HERETO
IRREVOCABLY WAIVES AND AGREES NOT TO ASSERT IN ANY PROCEEDING BEFORE ANY TRIBUNAL, BY WAY OF MOTION, AS A DEFENSE OR OTHERWISE,
ANY CLAIM THAT IT IS NOT SUBJECT TO THE IN PERSONAM JURISDICTION OF ANY SUCH COURT. IN ADDITION, EACH OF THE PARTIES HERETO IRREVOCABLY
WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE IN ANY SUIT,
ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY DOCUMENT, AGREEMENT OR TRANSACTION CONTEMPLATED HEREBY
BROUGHT IN ANY SUCH COURT, AND HEREBY IRREVOCABLY WAIVES ANY CLAIM THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH
COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.


 


(c)          Service
of Process. EACH PARTY HERETO IRREVOCABLY AGREES THAT PROCESS PERSONALLY SERVED OR SERVED BY U.S. REGISTERED MAIL AT THE ADDRESSES
PROVIDED HEREIN FOR NOTICES SHALL CONSTITUTE, TO THE EXTENT PERMITTED BY LAW, ADEQUATE SERVICE OF PROCESS IN ANY SUIT, ACTION OR
PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE WARRANTS OR ANY DOCUMENT, AGREEMENT OR TRANSACTION CONTEMPLATED HEREBY,
OR ANY ACTION OR PROCEEDING TO EXECUTE OR OTHERWISE ENFORCE ANY JUDGMENT IN RESPECT OF ANY BREACH HEREUNDER, UNDER THE WARRANTS
OR UNDER ANY DOCUMENT OR AGREEMENT CONTEMPLATED HEREBY. RECEIPT OF PROCESS SO SERVED SHALL BE CONCLUSIVELY PRESUMED AS EVIDENCED
BY A DELIVERY RECEIPT FURNISHED BY THE UNITED STATES POSTAL SERVICE OR ANY COMMERCIAL DELIVERY SERVICE.


 


[Remainder of page intentionally left blank;
next page is signature page]


 




    	-20-



    	 



    

 


IN WITNESS WHEREOF, the
Parties have executed this Agreement on the date first above written.


 


	 	COMPANY:
	 	 
	 	BioScrip, Inc.
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	 
	 	PURCHASERS:
	 	 
	 	Coliseum Capital Partners, L.P.
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	 
	 	Coliseum Capital Partners II, L.P.
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	 
	 	Blackwell Partners, LLC, Series A 
	 	 
	 	By:  Coliseum Capital Management, LLC
	 	Attorney-in-fact
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 


 




    	 



    	 



    

 


ATTACHMENT A


[FORM OF WARRANT CERTIFICATE]


 


THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED OR SOLD
EXCEPT IN A TRANSACTION REGISTERED UNDER SUCH ACT OR PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT OR
STATE SECURITIES LAWS. THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS OF A CERTAIN WARRANT AGREEMENT,
DATED AS OF MARCH 9, 2015, THE PROVISIONS OF WHICH ARE INCORPORATED HEREIN BY REFERENCE. A COPY OF SUCH AGREEMENT IS AVAILABLE
FROM THE COMPANY UPON REQUEST.


 


WARRANT CERTIFICATE


 


BIOSCRIP, INC.


No. WR- Warrants


 


Date: [•], 2015


 


This Warrant Certificate certifies that______________________,
or registered assigns, is the registered holder of _____________________(_______________________) Warrants. Each Warrant entitles
the owner thereof to purchase at any time on or after the date hereof and on or prior to the Expiration Time, one (1) fully paid
and nonassessable share of Common Stock, $0.0001 par value per share (the “Common Stock”), of BIOSCRIP, INC.,
a Delaware corporation (together with its successors and assigns, the “Company”), at a purchase price (subject
to adjustment as provided in the Warrant Agreement (as defined below), the “Exercise Price”) of $[•] per
share of Common Stock upon presentation and surrender of this Warrant Certificate to the Company with a duly executed election
to purchase and payment of the Exercise Price, all in the manner set forth in the Warrant Agreement (defined below). The number
of shares of Common Stock that may be initially purchased upon exercise of each Warrant and the Exercise Price are the number and
the Exercise Price as of the date hereof, and are subject to adjustment as referred to below.


 


The Warrants are issued pursuant to a Warrant
Agreement (as it may from time to time be amended or supplemented, the “Warrant Agreement”), dated as of March 9, 2015,
among the Company and the Purchasers named therein, and are subject to all of the terms, provisions and conditions thereof, which
Warrant Agreement is hereby incorporated herein by reference and made a part hereof and to which Warrant Agreement reference is
hereby made for a full description of the rights, obligations, duties and immunities of the Company and the holders of the Warrant
Certificates. Capitalized terms used, but not defined, herein have the respective meanings ascribed to them in the Warrant Agreement.
In the event of any conflict between this Warrant Certificate and the Warrant Agreement, the Warrant Agreement shall control and
govern.


 




    	Attachment A



    	 



    

 


As provided in the Warrant Agreement, the Exercise
Price and the number of shares of Common Stock that may be purchased upon the exercise of the Warrants evidenced by this Warrant
Certificate are, upon the happening of certain events, subject to modification and adjustment. Except as otherwise set forth in,
and subject to, the Warrant Agreement, the Expiration Time of this Warrant Certificate is as set forth in the Warrant Agreement.


 


Subject to the limitations set forth in the
Warrant Agreement, this Warrant Certificate shall be exercisable, at the election of the holder, at any time on or after the date
hereof and on or prior to the Expiration Time either as an entirety or in part from time to time. If this Warrant Certificate shall
be exercised in part, the holder shall be entitled to receive, upon surrender hereof, another Warrant Certificate or Warrant Certificates
for the number of Warrants not exercised. This Warrant Certificate, with or without other Warrant Certificates, upon surrender
in the manner set forth in the Warrant Agreement and subject to the conditions set forth in the Warrant Agreement, may be transferred
or exchanged for another Warrant Certificate or Warrant Certificates of like tenor evidencing Warrants entitling the holder to
purchase a like aggregate number of shares of Common Stock as the Warrants evidenced by the Warrant Certificate or Warrant Certificates
surrendered shall have entitled such holder to purchase.


 


Except as expressly set forth in the Warrant
Agreement, no holder of this Warrant Certificate shall be entitled to vote or receive distributions or be deemed for any purpose
the holder of shares of Common Stock or of any other Securities of the Company that may at any time be issued upon the exercise
hereof, nor shall anything contained in the Warrant Agreement or herein be construed to confer upon the holder hereof, as such,
any of the rights of a holder of a share of Common Stock in the Company or any right to vote upon any matter submitted to holders
of shares of Common Stock at any meeting thereof, or to give or withhold consent to any corporate action of the Company (whether
upon any recapitalization, issuance of stock, reclassification of Securities, change of par value, consolidation, merger, conveyance,
or otherwise), or to receive dividends or subscription rights, or otherwise, until the Warrant or Warrants evidenced by this Warrant
Certificate shall have been exercised as provided in the Warrant Agreement.


 


THIS WARRANT CERTIFICATE SHALL BE CONSTRUED
AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE COMPANY AND THE HOLDER HEREOF SHALL BE GOVERNED BY, THE INTERNAL LAWS OF
THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO THE CONFLICT OF LAWS RULES THEREOF TO THE EXTENT THAT ANY SUCH RULES WOULD REQUIRE
OR PERMIT THE APPLICATION OF THE LAWS OF ANY OTHER JURISDICTION, EXCEPT TO THE EXTENT THAT THE DELAWARE GENERAL CORPORATION LAW
SPECIFICALLY AND MANDATORILY APPLIES.


 




    	Attachment A



    	 



    

 


WITNESS the signature of a proper officer of the Company
as of the date first above written.


 


	 	BIOSCRIP, INC.
	 	By:	 
	 	Name:	 
	 	Title:	 


 




    	Attachment A



    	 



    

 


[FORM OF ASSIGNMENT]


(To be executed by the registered holder
if


such holder desires to transfer the Warrant
Certificate)


 


FOR VALUE RECEIVED, ________________________hereby sells,
assigns and transfers unto


 


                                                                                                                                                                                                                           


(Please print name and address of transferee.)


 


the accompanying Warrant Certificate, together with all right, title
and interest therein, and does hereby irrevocably constitute and appoint:


 


                                                                                                                                                                                                                           


 


attorney, to transfer the accompanying Warrant Certificate on the
books of the Company with full power of substitution.


 


Dated:                                    ,20 .


[HOLDER]


By:


 


NOTICE


The signature to the foregoing Assignment must correspond to the
name as written upon the face of the accompanying Warrant Certificate or any prior assignment thereof in every particular, without
alteration or enlargement or any change whatsoever.


 




    	Attachment A



    	 



    

 


 


[FORM OF ELECTION TO PURCHASE]


(To be executed by the registered holder
if


such holder desires to exercise the Warrant
Certificate)


 


To: BIOSCRIP, INC.


 


The undersigned hereby irrevocably elects to exercise_____________________Warrants
represented by the accompanying Warrant Certificate to purchase the shares of Common Stock issuable upon the exercise of such Warrants,
and requests that certificates for such shares be issued in the name of:


 


                                                                                                                                                                                                                           


(Please print name and address.)


 


                                                                                                                                                                                                                           


(Please insert social security or other identifying number.)


 


If such number of Warrants shall not be all the Warrants evidenced
by the accompanying Warrant Certificate, a new Warrant Certificate for the balance remaining of such Warrants shall be registered
in the name of and delivered to:


 


                                                                                                                                                                                                                           


(Please print name and address.)


 


                                                                                                                                                                                                                           


(Please insert social security or other identifying number.)


 


The undersigned is paying the Exercise Price for the Common Stock
to be issued on exercise of the foregoing Warrants, unless payment of such Exercise Price has been waived by the Company by certified
or bank check by wire transfer pursuant to Section 2.1(a)(i) of the Warrant Agreement.


 


Dated:                                    ,20 .


[HOLDER]


By:


 


NOTICE


The signature to the foregoing Election to Purchase must correspond
to the name as written upon the face of the accompanying Warrant Certificate or any prior assignment thereof in every particular,
without alteration or enlargement or any change whatsoever.


 




    	Attachment A



    	 



    

 


ANNEX 1


Warrants Issuable to the Purchasers


 


	Purchaser	 	Total No. of Warrants 

(No.1)	 	 	Total No. of Warrants 

(No.2)	 
	Coliseum Capital Partners, L.P.	 	 	1,133,188	 	 	 	1,133,188	 
	Coliseum Capital Partners II, L.P.	 	 	253,569	 	 	 	253,569	 
	Blackwell Partners, LLC, Series A	 	 	413,243	 	 	 	413,243	 



 




    	Annex 1



    	 



    

 


ANNEX 2


Address for Purchasers for Notices


 


Coliseum Capital Management, LLC


One Station Place, 7th Floor South


Stamford, CT 06902


Attention: Christopher Shackelton;


 


with a copy to:


 


Paul Hastings LLP


75 East 55th Street


New York, NY 10022


Attention: Barry A. Brooks


 




    	Annex 2



    	 



    

 


ANNEX 3


Address of Company for Notices


BioScrip, Inc.


100 Clearbrook Road


Elmsford, New York 10523


Attention: Chief Executive Officer


 


with a copy to:


 


Polsinelli PC


100 S. Fourth Street, Suite 1000


St. Louis, MO 63102


Attention: Mark H. Goran


 




    	Annex 3